Send me a link:

*Text messaging rates may apply.

 Dow Down0.02% Nasdaq Down0.04%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.35 0.03(2.17%) Jul 24, 4:02PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents32,939  9,119  28,644  
Short Term Investments -   -   -  
Net Receivables1,151  18  16  
Inventory2,232  298  822  
Other Current Assets1,009  1,184  565  
Total Current Assets 37,331   10,617   30,047  
Long Term Investments -   -   -  
Property Plant and Equipment2,125  935  463  
Goodwill -   -   -  
Intangible Assets137  92  85  
Accumulated Amortization26  23  21  
Other Assets723  328  599  
Deferred Long Term Asset Charges -   -   -  
Total Assets 40,317   11,972   31,194  
Liabilities
Current Liabilities
Accounts Payable7,195  3,434  2,780  
Short/Current Long Term Debt4,096  2,757  569  
Other Current Liabilities -   -   -  
Total Current Liabilities 11,291   6,191   3,348  
Long Term Debt31,265  6,930  6,456  
Other Liabilities1,770  257  257  
Deferred Long Term Liability Charges -   -   -  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 44,326   13,378   10,062  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock0  0  0  
Common Stock136  113  95  
Retained Earnings(317,257)(274,558)(245,357)
Treasury Stock -   -   -  
Capital Surplus313,112  273,039  266,394  
Other Stockholder Equity -   -   -  
Total Stockholder Equity (4,010) (1,405) 21,132  
Net Tangible Assets (4,146) (1,498) 21,046  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.